There is also evidence that NRF2 overexpression is associated with tumor grade, stage, invasion, and poor overall survival in upper tract urothelial cancer [49,54], which might be related to the catabolic metabolism of cancer cells in the metastatic phase versus an anabolic metabolism in early stages of cancer where nourished microenvironments predominate [43]. The gene discussed is NFE2L2; the disease is cancer.